Latest Breaking News On - Misleading statements regarding - Page 7 : comparemela.com

The Class: Shareholder rights law firm Robbins LLP informs investors that a shareholder filed a class action on behalf of all persons and entities that purchased Centessa Pharmaceuticals plc . | September 29, 2022

United statesAaron dumasCentessa pharmaceuticalsAmerican depository sharesCase aboutMade falseMisleading statements regardingProduct candidatesOffering documentsStock watchCentessa pharmaceuticals plc stock exchangePress releaseLc cnta us1523091007